Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9801.
-
Intersport Polska S.A. Convenes Extraordinary General Meeting for December 4, 2026Intersport Polska S.A. has announced the convocation of an Extraordinary General Meeting (NWZ) scheduled for December 4, 2026, at the company's headquarters in Cholerzyn.
-
EAM Solar Reports 9M 2026 Results and Enforcement of Aveleos DamagesEAM Solar announced its 9M 2026 financial results, highlighting a EUR 2.76 million EBITDA, debt reduction, and the commencement of enforcement for a EUR 4.4 million damages recovery.
-
Sweden Buyersclub Q3 2026 Earnings CallSweden Buyersclub AB held its Q3 2026 earnings call on November 3, 2026, to discuss the company's latest financial results.
-
Norwegian Block Exchange Wraps Up 10th Put Option PeriodNorwegian Block Exchange AS has concluded its 10th put option period, a recurring corporate event for the company.
-
Weng Fine Art AG Announces Correction of 2025 Financial StatementsWeng Fine Art AG has adjusted its 2025 annual financial statements, resulting in a reduction of projected net profit and equity due to inventory write-downs and other accounting adjustments.
-
Nordic Iron Ore AB Appoints Nomination Committee for 2027 Annual General MeetingNordic Iron Ore AB has appointed its Nomination Committee for the 2027 Annual General Meeting, consisting of representatives from its three largest shareholders.
-
Singulus Technologies AG: Voting Rights Notification (Peter R. Denton)Singulus Technologies AG published a formal voting rights notification regarding Peter R. Denton and Harvest Investors, L.P.
-
Remak-Energomontaż S.A. Management Board Position on Tender OfferThe Management Board of Remak-Energomontaż S.A. has issued its official position regarding the tender offer for the company's shares initiated by Zarmen sp. z o.o.
-
Fable Media Group: Comment on guidance adjustmentRedeye Nordic Growth AB has published a research note regarding a guidance adjustment for Fable Media Group.
-
K2G Holding AG Subsidiary In-Revento Partners with ecore for MyGenny.bro LaunchK2G Holding AG's subsidiary, In-Revento, has partnered with ecore to launch the MyGenny.bro insurance comparison module, with a target of 4,000 licenses by 2029.
-
Regenbogen AG Receives Expert Valuation for Prerow Compensation ClaimRegenbogen AG announced that an independent expert has valued the structural facilities at its former Prerow camping site at 5.8 million EUR as of December 31, 2023.
-
Berentzen-Gruppe Boards Recommend Sazerac Takeover OfferThe Executive Board and Supervisory Board of Berentzen-Gruppe AG have officially recommended that shareholders accept the takeover offer from Sazerac.
-
Climeon Reports Q3 2026 Financial Results and Operational UpdatesClimeon reported its third-quarter 2026 financial results, showing a narrowed operating loss and the completion of a SEK 50 million directed share issue.
-
bet-at-home.com AG Lowers 2026 Earnings GuidanceThe company has revised its financial outlook for the 2026 fiscal year, lowering its EBITDA and gross betting and gaming revenue (GGR) expectations.
-
NuWays AG Reaffirms Buy Rating and Guidance for NanoRepro AGEquity research firm NuWays AG has reiterated its 'BUY' rating for NanoRepro AG, confirming the company's long-term sales targets.
-
ABG Sundal Collier Downgrades Coloplast to 'Sell'ABG Sundal Collier has downgraded its rating for Coloplast from 'Hold' to 'Sell', setting a new price target of 420 Danish kroner.
-
Più Medical Completes Acquisition of 60% Stake in Farmacia dell'AquilaPiù Medical S.p.A. has finalized the acquisition of a 60% controlling interest in the Italian pharmacy Farmacia dell'Aquila.
-
Artmarket.com Releases Spanish Edition of AI-Focused WorkArtmarket.com has published a complete Spanish-language edition of its 1,800-page work, "Dialogue Between a Thinker and AI," for free worldwide download.
-
Corline Biomedical Issues 2026 Financial Forecast and 2027 GuidanceCorline Biomedical AB has released a financial forecast for 2026 and provided guidance for 2027, citing recent customer orders and projections.
-
Pentixapharm Reports Progress on Pivotal Phase 3 PANDA StudyPentixapharm Holding AG has completed key preparatory work for its pivotal Phase 3 PANDA study and announced a date for its third-quarter 2026 financial results.